Interestingly, we recently found that activated form of MAP kinase (ERK) was decreased in BRCA1-suppressed ovarian carcinoma cells (data not shown), and this may be consistent with that activated ERK is reported to work as anti-apoptotic signal (Ohmichi et al. 2005). Here, BRCA1 is linked to ovarian carcinoma.